Bristol Myers Squibb (CELG-RI) Current Assets (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Current Assets data on file, last reported at $27.2 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $27.2 billion, down 11.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.2 billion (down 11.61% YoY), and the FY2025 annual result was $29.4 billion, down 1.31% from the prior year.
• Current Assets fell to $27.2 billion in Q1 2026 per CELG-RI's latest filing, from $29.4 billion in the prior quarter.
• Over five years, Current Assets peaked at $35.6 billion in Q3 2025 and troughed at $26.8 billion in Q3 2022.
• A 5-year average of $29.3 billion and a median of $28.7 billion in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2025: Current Assets decreased 18.01% in 2022, then climbed 26.91% in 2025.
• A 5-year view of Current Assets shows it stood at $27.3 billion in 2022, then rose by 16.49% to $31.8 billion in 2023, then dropped by 6.26% to $29.8 billion in 2024, then fell by 1.31% to $29.4 billion in 2025, then dropped by 7.42% to $27.2 billion in 2026.
• Business Quant data shows CELG-RI's Current Assets at $27.2 billion in Q1 2026, $29.4 billion in Q4 2025, and $35.6 billion in Q3 2025.